Brief: Alumis Stockholders Approve Merger With Acelyrin
13/05/2025 18:05
May 13 (Reuters) - Alumis Inc ALMS.O: ALUMIS STOCKHOLDERS APPROVE MERGER WITH ACELYRIN ALUMIS INC - MERGER EXPECTED TO CLOSE IN Q2 2025 Source text: ID:nGNXbDPfFW Further company coverage: ALMS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alumis
See all newsBrief: Alumis Says Envudeucitinib Improves Psoriasis Symptoms in Phase 3 Data
U.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Alumis set for worst day after lupus drug misses main goal in mid-stage trial
Alumis eyes late-stage lupus study despite trial miss (updated)
Alumis tumbles after lupus drug misses main goal in mid-stage trial